Weeks after IPO, Peninsula drug maker lines up Asian cancer-fighting deal

The South San Francisco company's drug, currently in an early-phase clinical trial, targets types of breast and lung cancers as well as gastric cancer, which Asian drug makers are anxious to tackle.

Source: bizjournals.com Health Care:Biotechnology headlines - December 4, 2019 Category: Biotechnology Authors: Ron Leuty Source Type: news